Kyverna Therapeutics is a pharmaceutical company that generates treatments and potential cures for autoimmune diseases. It develops a therapeutic platform that combines T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the root cause of inflammatory diseases.